Author: Nilsson, Per H; Ekdahl, Kristina N; Magnusson, Peetra U; Qu, Hongchang; Iwata, Hiroo; Ricklin, Daniel; Hong, Jaan; Lambris, John D; Nilsson, Bo; Teramura, Yuji
Title: Autoregulation of thromboinflammation on biomaterial surfaces by a multicomponent therapeutic coating Cord-id: qqo8f2k7 Document date: 2013_1_1
ID: qqo8f2k7
Snippet: Activation of the thrombotic and complement systems is the main recognition and effector mechanisms in the multiple adverse biological responses triggered when biomaterials or therapeutic cells come into blood contact. We have created a surface which is auto-protective to human innate immunity by combining three fundamentally different strategies, all developed by us previously, which have been shown to induce substantial, but incomplete hemocompatibility when used separately. In summary, we hav
Document: Activation of the thrombotic and complement systems is the main recognition and effector mechanisms in the multiple adverse biological responses triggered when biomaterials or therapeutic cells come into blood contact. We have created a surface which is auto-protective to human innate immunity by combining three fundamentally different strategies, all developed by us previously, which have been shown to induce substantial, but incomplete hemocompatibility when used separately. In summary, we have conjugated a factor H –binding peptide; and an ADP-degrading enzyme; using a PEG linker on both material and cellular surfaces. When exposed to human whole blood, factor H was specifically recruited to the modified surfaces and inhibited complement attack. In addition, activation of platelets and coagulation was efficiently attenuated, by degrading ADP. Thus, by inhibiting thromboinflammation using a multicomponent approach, we have created a hybrid surface with the potential to greatly reduce incompatibility reactions involving biomaterials and transplantation.
Search related documents:
Co phrase search for related documents- absence presence and active conformation: 1, 2, 3
- absence presence and acute immune response: 1, 2
- absence presence and acute injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- absence presence and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- absence presence and adherent cell: 1
- absence presence and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9
- absence presence and lung injury: 1, 2, 3, 4
- absence presence and lysine residue: 1
- accumulation neutrophil and acute injury: 1, 2, 3, 4
- accumulation neutrophil and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7
- accumulation neutrophil and lung inflammation: 1, 2, 3
- accumulation neutrophil and lung injury: 1, 2, 3, 4, 5, 6, 7
Co phrase search for related documents, hyperlinks ordered by date